Federated Hermes
ATXS

Federated Hermes’s Astria Therapeutics ATXS Stock Holding History

Federated Hermes’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-84
Closed -$1.18K – 2028
2024
Q1 		$1.18K Buy
+84
New +$1.05K ﹤0.01% 1950
2022
Q1 		– Sell
-64
Closed -$1K – 2189
2021
Q4 		$1K Buy
64
+26
+68% +$171 ﹤0.01% 2088
2021
Q3 		$1K Sell
38
-1
-3% -$10 ﹤0.01% 2122
2021
Q2 		$1K Buy
+39
New +$506 ﹤0.01% 2114
2020
Q4 		– Sell
-507,967
Closed -$18.9M – 2241
2020
Q3 		$18.9M Hold
507,967
– – 0.04% 420
2020
Q2 		$19.6M Hold
507,967
– – 0.05% 399
2020
Q1 		$12.6M Buy
507,967
+154,167
+44% +$4.78M 0.04% 426
2019
Q4 		$12.5M Sell
353,800
-11,100
-3% -$350K 0.03% 545
2019
Q3 		$11.8M Hold
364,900
– – 0.03% 520
2019
Q2 		$17.7M Hold
364,900
– – 0.04% 381
2019
Q1 		$17.3M Buy
364,900
+191,000
+110% +$6.48M 0.04% 380
2018
Q4 		$4.56M Hold
173,900
– – 0.01% 759
2018
Q3 		$8.35M Hold
173,900
– – 0.02% 636
2018
Q2 		$10M Buy
+173,900
New +$16M 0.03% 454
2017
Q1 		– Sell
-2,667
Closed -$578K – 2122
2016
Q4 		$578K Buy
2,667
+829
+45% +$203K ﹤0.01% 1273
2016
Q3 		$679K Sell
1,838
-162
-8% -$42.7K ﹤0.01% 1200
2016
Q2 		$444K Hold
2,000
– – ﹤0.01% 1306
2016
Q1 		$605K Buy
2,000
+667
+50% +$230K ﹤0.01% 1228
2015
Q4 		$634K Buy
1,333
+500
+60% +$240K ﹤0.01% 1223
2015
Q3 		$405K Hold
833
– – ﹤0.01% 1338
2015
Q2 		$611K Buy
+833
New +$630K ﹤0.01% 1282

Other funds holding ATXS

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Federated Hermes's ATXS Position: Q2 2024 in Review

Federated Hermes sold out of Astria Therapeutics (ATXS) in Q2 2024, closing a stake of 84 shares — an estimated $1.18K sold.

Federated Hermes first reported a position in ATXS in Q2 2015 and held it in 21 quarters. The position peaked at $19.6M in Q2 2020. 100 funds tracked by Wall St. Rank hold ATXS as of Q2 2024.

  • Federated Hermes reported no remaining Astria Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Federated Hermes sold 84 Astria Therapeutics shares in Q2 2024, an estimated $1.18K.
  • Federated Hermes first reported a position in Astria Therapeutics in Q2 2015 and held it in 21 quarters.
  • Federated Hermes's Astria Therapeutics position peaked at $19.6M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2024.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.